Metraipolis › archive › dc_fbced9fef51d

Organoid platinum-resistance model identifies KRT17 as a biomarker of targeted therapy in ovarian cancer — Europe PMC PMID:41399494

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41399494
DOI: 10.1016/j.isci.2025.113999
License (as archived): solo-consultazione
Archived: 2026-11-08T17:02:29.253Z
SHA-256 of the archived text: f5fefd34319d5763940cdb4f08ba5d23e795f40ee9b0155c11ac3909ed82c4c5
Stable URL of this page: https://metraipolis.com/documento/dc_fbced9fef51d

How to cite

Organoid platinum-resistance model identifies KRT17 as a biomarker of targeted therapy in ovarian cancer — Europe PMC PMID:41399494 — Europe PMC (en), https://europepmc.org/article/MED/41399494 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fbced9fef51d (Metraipolis archive dc_fbced9fef51d, sha256 f5fefd34319d5763940cdb4f08ba5d23e795f40ee9b0155c11ac3909ed82c4c5)

BibTeX

@misc{dcfbced9fef51d,
  title = {Organoid platinum-resistance model identifies KRT17 as a biomarker of targeted therapy in ovarian cancer — Europe PMC PMID:41399494},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41399494},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fbced9fef51d; sha256 f5fefd34319d5763940cdb4f08ba5d23e795f40ee9b0155c11ac3909ed82c4c5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41399494. Agents can read the archived copy with the MCP tool read_document.